What to Expect from the Next Wave of ANVISA-Approved Weight Loss Pens: Beyond Semaglutide
Brazil's health regulator is evaluating the next generation of weight loss injections. Here's what patients and healthcare providers should know about upcoming GLP-1 medications approved by ANVISA.